In 153 patients with high-risk muscle-invasive bladder cancer after cystectomy and chemotherapy, adjuvant pelvic radiotherapy improved 2-year locoregional recurrence-free survival vs observation (87.1% v 76.0%; HR 0.43). Secondary DFS and OS differences were not significant.
RCTn = 153
Murthy et al. Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer